Literature DB >> 23553552

Noninvasive fetal genome sequencing: a primer.

Matthew W Snyder1, LaVone E Simmons, Jacob O Kitzman, Donna A Santillan, Mark K Santillan, Hilary S Gammill, Jay Shendure.   

Abstract

We recently demonstrated whole genome sequencing of a human fetus using only parental DNA samples and plasma from the pregnant mother. This proof-of-concept study demonstrated how samples obtained noninvasively in the first or second trimester can be analyzed to yield a highly accurate and substantially complete genetic profile of the fetus, including both inherited and de novo variation. Here, we revisit our original study from a clinical standpoint, provide an overview of the scientific approach, and describe opportunities and challenges along the path toward clinical adoption of noninvasive fetal whole genome sequencing.
© 2013 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23553552      PMCID: PMC3727971          DOI: 10.1002/pd.4097

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  41 in total

1.  Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus.

Authors:  Y M Dennis Lo; K C Allen Chan; Hao Sun; Eric Z Chen; Peiyong Jiang; Fiona M F Lun; Yama W Zheng; Tak Y Leung; Tze K Lau; Charles R Cantor; Rossa W K Chiu
Journal:  Sci Transl Med       Date:  2010-12-08       Impact factor: 17.956

2.  Reevaluating confined placental mosaicism.

Authors:  Gail Stetten; Cathleen S Escallon; Sarah T South; Joseph L McMichael; Daniel O Saul; Karin J Blakemore
Journal:  Am J Med Genet A       Date:  2004-12-15       Impact factor: 2.802

3.  ACOG Practice Bulletin No. 77: screening for fetal chromosomal abnormalities.

Authors: 
Journal:  Obstet Gynecol       Date:  2007-01       Impact factor: 7.661

4.  Differential DNA methylation between fetus and mother as a strategy for detecting fetal DNA in maternal plasma.

Authors:  Leo L M Poon; Tse N Leung; Tze K Lau; Katherine C K Chow; Y M Dennis Lo
Journal:  Clin Chem       Date:  2002-01       Impact factor: 8.327

5.  FetalQuant: deducing fractional fetal DNA concentration from massively parallel sequencing of DNA in maternal plasma.

Authors:  Peiyong Jiang; K C Allen Chan; Gary J W Liao; Yama W L Zheng; Tak Y Leung; Rossa W K Chiu; Yuk Ming Dennis Lo; Hao Sun
Journal:  Bioinformatics       Date:  2012-09-08       Impact factor: 6.937

6.  Fetal lymphocytes in the maternal blood.

Authors:  J Schröder; A De la Chapelle
Journal:  Blood       Date:  1972-02       Impact factor: 22.113

7.  Whole-genome molecular haplotyping of single cells.

Authors:  H Christina Fan; Jianbin Wang; Anastasia Potanina; Stephen R Quake
Journal:  Nat Biotechnol       Date:  2010-12-19       Impact factor: 54.908

8.  Chromosomal microarray versus karyotyping for prenatal diagnosis.

Authors:  Ronald J Wapner; Christa Lese Martin; Brynn Levy; Blake C Ballif; Christine M Eng; Julia M Zachary; Melissa Savage; Lawrence D Platt; Daniel Saltzman; William A Grobman; Susan Klugman; Thomas Scholl; Joe Leigh Simpson; Kimberly McCall; Vimla S Aggarwal; Brian Bunke; Odelia Nahum; Ankita Patel; Allen N Lamb; Elizabeth A Thom; Arthur L Beaudet; David H Ledbetter; Lisa G Shaffer; Laird Jackson
Journal:  N Engl J Med       Date:  2012-12-06       Impact factor: 91.245

9.  Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders.

Authors:  Brian J O'Roak; Laura Vives; Wenqing Fu; Jarrett D Egertson; Ian B Stanaway; Ian G Phelps; Gemma Carvill; Akash Kumar; Choli Lee; Katy Ankenman; Jeff Munson; Joseph B Hiatt; Emily H Turner; Roie Levy; Diana R O'Day; Niklas Krumm; Bradley P Coe; Beth K Martin; Elhanan Borenstein; Deborah A Nickerson; Heather C Mefford; Dan Doherty; Joshua M Akey; Raphael Bernier; Evan E Eichler; Jay Shendure
Journal:  Science       Date:  2012-11-15       Impact factor: 47.728

10.  Rate of de novo mutations and the importance of father's age to disease risk.

Authors:  Augustine Kong; Michael L Frigge; Gisli Masson; Soren Besenbacher; Patrick Sulem; Gisli Magnusson; Sigurjon A Gudjonsson; Asgeir Sigurdsson; Aslaug Jonasdottir; Adalbjorg Jonasdottir; Wendy S W Wong; Gunnar Sigurdsson; G Bragi Walters; Stacy Steinberg; Hannes Helgason; Gudmar Thorleifsson; Daniel F Gudbjartsson; Agnar Helgason; Olafur Th Magnusson; Unnur Thorsteinsdottir; Kari Stefansson
Journal:  Nature       Date:  2012-08-23       Impact factor: 49.962

View more
  7 in total

1.  "This lifetime commitment": Public conceptions of disability and noninvasive prenatal genetic screening.

Authors:  Rosemary J Steinbach; Megan Allyse; Marsha Michie; Emily Y Liu; Mildred K Cho
Journal:  Am J Med Genet A       Date:  2015-11-14       Impact factor: 2.802

Review 2.  Integration of noninvasive DNA testing for aneuploidy into prenatal care: what has happened since the rubber met the road?

Authors:  Diana W Bianchi; Louise Wilkins-Haug
Journal:  Clin Chem       Date:  2013-11-19       Impact factor: 8.327

Review 3.  Genetic determinants of fetal opiate exposure and risk of neonatal abstinence syndrome: Knowledge deficits and prospects for future research.

Authors:  T Lewis; J Dinh; J S Leeder
Journal:  Clin Pharmacol Ther       Date:  2015-07-22       Impact factor: 6.875

4.  Defining "mutation" and "polymorphism" in the era of personal genomics.

Authors:  Roshan Karki; Deep Pandya; Robert C Elston; Cristiano Ferlini
Journal:  BMC Med Genomics       Date:  2015-07-15       Impact factor: 3.063

5.  DFLAT: functional annotation for human development.

Authors:  Heather C Wick; Harold Drabkin; Huy Ngu; Michael Sackman; Craig Fournier; Jessica Haggett; Judith A Blake; Diana W Bianchi; Donna K Slonim
Journal:  BMC Bioinformatics       Date:  2014-02-07       Impact factor: 3.169

6.  Noninvasive prenatal exome sequencing diagnostic utility limited by sequencing depth and fetal fraction.

Authors:  Dayne L Filer; Piotr A Mieczkowski; Alicia Brandt; Kelly L Gilmore; Bradford C Powell; Jonathan S Berg; Kirk C Wilhelmsen; Neeta L Vora
Journal:  Prenat Diagn       Date:  2021-07-21       Impact factor: 3.242

Review 7.  Microarray Technology for the Diagnosis of Fetal Chromosomal Aberrations: Which Platform Should We Use?

Authors:  Evangelia Karampetsou; Deborah Morrogh; Lyn Chitty
Journal:  J Clin Med       Date:  2014-06-20       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.